348 related articles for article (PubMed ID: 28172715)
1. Atrial high-rate episodes and stroke prevention.
Camm AJ; Simantirakis E; Goette A; Lip GY; Vardas P; Calvert M; Chlouverakis G; Diener HC; Kirchhof P
Europace; 2017 Feb; 19(2):169-179. PubMed ID: 28172715
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices.
Spartalis M; Kontogiannis C; Spartalis E; Iliopoulos DC; Siasos G
Curr Pharm Des; 2024; 30(7):485-488. PubMed ID: 38343055
[TBL] [Abstract][Full Text] [Related]
3. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
[TBL] [Abstract][Full Text] [Related]
4. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
[TBL] [Abstract][Full Text] [Related]
5. What to do with device-detected atrial high-rate episodes: Summary of the evidences.
Özge Mert G; Kepez A; Uğur Mert K; Görenek B
Pacing Clin Electrophysiol; 2022 Feb; 45(2):250-261. PubMed ID: 34927268
[TBL] [Abstract][Full Text] [Related]
6. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
[TBL] [Abstract][Full Text] [Related]
7. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
Tomita H; Sasaki S; Hagii J; Metoki N
J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
[TBL] [Abstract][Full Text] [Related]
8. Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.
Bertaglia E; Blank B; Blomström-Lundqvist C; Brandes A; Cabanelas N; Dan GA; Dichtl W; Goette A; de Groot JR; Lubinski A; Marijon E; Merkely B; Mont L; Piorkowski C; Sarkozy A; Sulke N; Vardas P; Velchev V; Wichterle D; Kirchhof P
Europace; 2019 Oct; 21(10):1459-1467. PubMed ID: 31377792
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.
Boriani G; Healey JS; Schnabel RB; Lopes RD; Calkins H; Camm JA; Freedman B
Int J Cardiol; 2019 Dec; 296():65-70. PubMed ID: 31327519
[TBL] [Abstract][Full Text] [Related]
10. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update.
Toennis T; Bertaglia E; Brandes A; Dichtl W; Fluschnik N; de Groot JR; Marijon E; Mont L; Lundqvist CB; Cabanelas N; Dan GA; Lubinski A; Merkely B; Rajappan K; Sarkozy A; Velchev V; Wichterle D; Kirchhof P
Europace; 2023 Jul; 25(7):. PubMed ID: 37345804
[TBL] [Abstract][Full Text] [Related]
11. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Di Cori A; Lilli A; Zucchelli G; Zaca V
Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h.
Becher N; Toennis T; Bertaglia E; Blomström-Lundqvist C; Brandes A; Cabanelas N; Calvert M; Camm AJ; Chlouverakis G; Dan GA; Dichtl W; Diener HC; Fierenz A; Goette A; de Groot JR; Hermans ANL; Lip GYH; Lubinski A; Marijon E; Merkely B; Mont L; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Schnabel RB; Schotten U; Sehner S; Simantirakis E; Vardas P; Velchev V; Wichterle D; Zapf A; Kirchhof P
Eur Heart J; 2024 Mar; 45(10):837-849. PubMed ID: 37956458
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Oral Anticoagulation in Patients with Atrial High-rate Episodes.
Marinheiro R; Parreira L; Amador P; Lopes C; Fernandes A; Mesquita D; Farinha J; Fonseca M; Duarte T; Caria R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):971-979. PubMed ID: 30642667
[TBL] [Abstract][Full Text] [Related]
14. Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation.
Miyazawa K; Pastori D; Lip GYH
Prog Cardiovasc Dis; 2018; 60(4-5):537-541. PubMed ID: 29289494
[TBL] [Abstract][Full Text] [Related]
15. [Device-detected atrial arrhythmia - when is anticoagulation indicated?].
Almqvist M; Mattsson G; Magnusson P
Lakartidningen; 2019 Aug; 116():. PubMed ID: 31408188
[TBL] [Abstract][Full Text] [Related]
16. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
17. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
[TBL] [Abstract][Full Text] [Related]
18. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
Khan AA; Boriani G; Lip GYH
Clin Res Cardiol; 2020 Apr; 109(4):409-416. PubMed ID: 31522249
[TBL] [Abstract][Full Text] [Related]
19. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
[TBL] [Abstract][Full Text] [Related]
20. Atrial high rate episodes in patients with dual-chamber cardiac implantable electronic devices: unmasking silent atrial fibrillation.
Benezet-Mazuecos J; Rubio JM; Farré J
Pacing Clin Electrophysiol; 2014 Aug; 37(8):1080-6. PubMed ID: 24888216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
